Algorae Pharmaceuticals (1AI) Short Interest
Algorae Pharmaceuticals (ASX:1AI) had 0.00% of shares reported as short positions as of 17 Aug 2026, representing 16,823 shares. Algorae Pharmaceuticals operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Algorae Pharmaceuticals
Algorae Pharmaceuticals Limited focuses on the development and commercialization of innovative pharmaceuticals and biotechnology products. The company leverages cutting-edge research to address unmet medical needs across various therapeutic areas. Its market position is bolstered by a robust pipeline of drugs that target specific industry demands, making it a key player in pharmaceutical innovation.
Short position
Algorae Pharmaceuticals (ASX:1AI) has 0.00% of its shares on issue reported as short positions as of 17 Aug 2026, or about 16,823 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. 1AI is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 34, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+41AI intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Algorae Pharmaceuticals
Latest 1AI news
All news- Quarterly Activities Report/Appendix 4C Cashflow Statement
asx
- Algorae Pharmaceuticals Announces Forfeiture of 35 Million Performance Rights After Conditions Not Met
kalkine
- Algorae Pharmaceuticals Announces Bradley Dilkes' Departure with Final Director Interest Disclosure
kalkine
- Initial Director's Interest Notice - TV
asx
- Final Director's Interest Notice - BD
asx
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss 1AI
Start a research thread or post the first pulse update